Reduced glucose metabolism is observed in the motor-sensory cortex of ALS patients and the frontal lobes, striatum, and thalamus of FTD patients, including in asymptomatic carriers of the ALS/FTD-linked C9orf72 mutation32–34. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.